In an oversubscribed series A, Recode closes on $80M March 26, 2020 By Lee Landenberger No Comments Privately held Recode Therapeutics Inc. brought in $80 million through an oversubscribed series A financing with plans to continue its preclinical work in primary ciliary dyskinesia (PCD) and cystic fibrosis (CF).Read More